Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor

Bispecific T-cell engager antibodies (BiTE) have been explored as a means to recruit cytolytic T cells to kill tumor cells. The transferrin receptor (TfR) is highly expressed on the surface of rapidly proliferating tumor cells. Therefore, it holds great potential in T cell redirecting therapies. In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Fu, Mingpeng, He, Qi, Guo, Zilong, Zhou, Xiaoran, Li, Heli, Zhao, Liang, Tang, Hongling, Zhou, Xiaoqi, Zhu, Huifen, Shen, Guanxin, He, Yong, Lei, Ping
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598450/
https://ncbi.nlm.nih.gov/pubmed/31293575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01396
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados